PML diagnostic criteria: Consensus statement from the AAN neuroinfectious disease section

Neurology

Volumn 80, Issue 15, 2013, Pages 1430-1438

  Berger, Joseph R ^a   Aksamit, Allen J ^b   Clifford, David B ^c   Davis, Larry ^d   Koralnik, Igor J ^e,f   Sejvar, James J ^g   Bartt, Russell ^h   Major, Eugene O ⁱ   Nath, Avindra ⁱ  

^a UNIVERSITY OF KENTUCKY   (United States)

^b MAYO CLINIC   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h Blue Sky Neurosciences   (United States)

ⁱ NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ASTROCYTE; BRAIN ANGIOGRAPHY; BRAIN BIOPSY; CD4 LYMPHOCYTE COUNT; CELL NUCLEUS; CEREBROSPINAL FLUID; CLINICAL FEATURE; CONSENSUS; CONTRAST ENHANCEMENT; DEMYELINATION; DIFFUSION WEIGHTED IMAGING; DISEASE CLASSIFICATION; FALSE POSITIVE RESULT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; JC VIRUS; META ANALYSIS; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGODENDROGLIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEREOTACTIC BIOPSY; SYSTEMATIC REVIEW;

BRAIN; CONSENSUS; DATABASES, FACTUAL; FEMALE; HIV INFECTIONS; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING; OLIGODENDROGLIA;

EID: 84876266893     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31828c2fa1     Document Type: Review

References (60)

1. Kleinschmidt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 2005; 353: 369-374.
2. Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005; 353: 375-381.
3. Van Assche G, Van Ranst M, Sciot R, et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 2005; 353: 362-368.
4. Berger JR. Progressive multifocal leukoencephalopathy and newer biological agents. Drug Saf 2010; 33: 969-983.
5. Astrom KE, Mancall EL, Richardson EP Jr. Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958; 81: 93-111.
6. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; 1: 1257-1260.
7. Aksamit AJ, Sever JL, Major EO. Progressive multifocal leukoencephalopathy: JC virus detection by in situ hybridization compared with immunohistochemistry. Neurology 1986; 36: 499-504.
8. Arthur RR, Dagostin S, Shah KV. Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction. J Clin Microbiol 1989; 27: 1174-1179.
9. Koralnik IJ, Wuthrich C, Dang X, et al. JC virus granule cell neuronopathy: a novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann Neurol 2005; 57: 576-580.
10. Wuthrich C, Dang X, Westmoreland S, et al. Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons. Ann Neurol 2009; 65: 742-748.
11. Richardson E Jr. Progressive multifocal leukoencephalopathy. N Engl J Med 1961; 265: 815-823.
12. Dang X, Koralnik IJ. A granule cell neuron-associated JC virus variant has a unique deletion in the VP1 gene. J Gen Virol 2006; 87: 2533-2537.
13. White MK, Khalili K. Pathogenesis of progressive multi-focal leukoencephalopathy: revisited. J Infect Dis 2011; 203: 578-586.
14. Mentzer D, Prestel J, Adams O, et al. Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies. J Neurol Neurosurg Psychiatry 2012; 83: 927-933.
15. Richardson EP Jr, Webster HD. Progressive multifocal leukoencephalopathy: its pathological features. Prog Clin Biol Res 1983; 105: 191-203.
16. Mazlo M, Tariska I. Are astrocytes infected in progressive multifocal leukoencephalopathy (PML)? Acta Neuropathol 1982; 56: 45-51.
17. Wuthrich C, Cheng YM, Joseph JT, et al. Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol 2009; 68: 15-25.
18. Wuthrich C, Koralnik IJ. Frequent infection of cortical neurons by JC virus in patients with progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol 2012; 71: 54-65.
19. Samorei IW, Schmid M, Pawlita M, et al. High sensitivity detection of JC-virus DNA in postmortem brain tissue by in situ PCR. J Neurovirol 2000; 6: 61-74.
20. Kepes JJ, Chou SM, Price LW Jr. Progressive multifocal leukoencephalopathy with 10-year survival in a patient with nontropical sprue: report of a case with unusual light and electron microscopic features. Neurology 1975; 25: 1006-1012.
21. Bernal-Cano F, Joseph JT, Koralnik IJ. Spinal cord lesions of progressive multifocal leukoencephalopathy in an acquired immunodeficiency syndrome patient. J Neurovirol 2007; 13: 474-476.
22. Whiteman ML, Post MJ, Berger JR, Tate LG, Bell MD, Limonte LP. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 1993; 187: 233-240.
23. Berger JR, Pall L, Lanska D, Whiteman M. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 1998; 4: 59-68.
24. Clifford DB, De Luca A, Simpson DM, Arendt G, Giovannoni G, Nath A. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 2010; 9: 438-446.
25. Tan IL, McArthur JC, Clifford DB, Major EO, Nath A. Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology 2011; 77: 1061-1067.
26. Yousry TA, Pelletier D, Cadavid D, et al. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 2012; 72: 779-787.
27. Harrison DM, Newsome SD, Skolasky RL, McArthur JC, Nath A. Immune reconstitution is not a prognostic factor in progressive multifocal leukoencephalopathy. J Neuroimmunol 2011; 238: 81-86.
28. Yousry TA, Major EO, Ryschkewitsch C, et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 2006; 354: 924-933.
29. Miller RF, Lucas SB, Hall-Craggs MA, et al. Comparison of magnetic resonance imaging with neuropathological findings in the diagnosis of HIV and CMV associated CNS disease in AIDS. J Neurol Neurosurg Psychiatry 1997; 62: 346-351.
30. Clifford DB, Arribas JR, Storch GA, Tourtellote W, Wippold FJ. Magnetic resonance brain imaging lacks sensitivity for AIDS associated cytomegalovirus encephalitis. J Neurovirol 1996; 2: 397-403.
31. Gray F, Belec L, Lescs MC, et al. Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain 1994; 117: 987-999.
32. Berger JR, Scott G, Albrecht J, Belman AL, Tornatore C, Major EO. Progressive multifocal leukoencephalopathy in HIV-1-infected children. AIDS 1992; 6: 837-841.
33. Bhigjee AI, Patel VB, Bhagwan B, Moodley AA, Bill PL. HIV and acute disseminated encephalomyelitis [letter]. S Afr Med J 1999; 89: 283-284.
34. Scaravilli F, Daniel SE, Harcourt-Webster N, Guiloff RJ. Chronic basal meningitis and vasculitis in acquired immunodeficiency syndrome: a possible role for human immunodeficiency virus [see comments]. Arch Pathol Lab Med 1989; 113: 192-195.
35. Church JA. Reversible leukoencephalopathy in a patient with nucleoside analogue-associated mitochondrial DNA depletion and metabolic disease. AIDS 2002; 16: 2366-2367.
36. Brochet B, Dousset V. Pathological correlates of magnetization transfer imaging abnormalities in animal models and humans with multiple sclerosis. Neurology 1999; 53:S12-S17.
37. Chang L, Ernst T, Tornatore C, et al. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology 1997; 48: 836-845.
38. Nelson PK, Masters LT, Zagzag D, Kelly PJ. Angiographic abnormalities in progressive multifocal leukoencephalopathy: an explanation based on neuropathologic findings. AJNR Am J Neuroradiol 1999; 20: 487-494.
39. Iranzo A, Marti-Fabregas J, Domingo P, et al. Absence of thallium-201 brain uptake in progressive multifocal leuko-encephalopathy in AIDS patients. Acta Neurol Scand 1999; 100: 102-105.
40. Port JD, Miseljic S, Lee RR, et al. Progressive multifocal leukoencephalopathy demonstrating contrast enhancement on MRI and uptake of thallium-201: a case report. Neuroradiology 1999; 41: 895-898.
41. Lee VW, Antonacci V, Tilak S, Fuller JD, Cooley TP. Intracranial mass lesions: sequential thallium and gallium scintigraphy in patients with AIDS. Radiology 1999; 211: 507-512.
42. O'Doherty MJ, Barrington SF, Campbell M, Lowe J, Bradbeer CS. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med 1997; 38: 1575-1583.
43. Mertens K, Acou M, Van den Broecke C, et al. Progressive multifocal leukoencephalopathy (PML) mimicking highgrade glioma on delayed F-18 FDG PET imaging. J Clin Neurosci 2012; 19: 1167-1169.
44. Fong IW, Britton CB, Luinstra KE, Toma E, Mahony JB. Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol 1995; 33: 484-486.
45. Marshall DW, Brey RL, Cahill WT, Houk RW, Zajac RA, Boswell RN. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 1988; 45: 954-958.
46. McGuire D, Barhite S, Hollander H, Miles M. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy [erratum 1995; 37: 687]. Ann Neurol 1995; 37: 395-399.
47. Weber T, Turner RW, Frye S, et al. Progressive multifocal leukoencephalopathy diagnosed by amplification of JC virus-specific DNA from cerebrospinal fluid. AIDS 1994; 8: 49-57.
48. Cinque P, Koralnik IJ, Clifford DB. The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology. J Neurovirol 2003; 9(suppl 1): 88-92.
49. Drews K, Bashir T, Dorries K. Quantification of human polyomavirus JC in brain tissue and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy by competitive PCR. J Virol Methods 2000; 84: 23-36.
50. Iacobaeus E, Ryschkewitsch C, Gravell M, et al. Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA. Mult Scler 2009; 15: 28-35.
51. Kuhle J, Gosert R, Buhler R, et al. Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated MS patient. Neurology 2011; 77: 2010-2016.
52. Marzocchetti A, Di Giambenedetto S, Cingolani A, Ammassari A, Cauda R, De Luca A. Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoen-cephalopathy in the era of potent antiretroviral therapy. J Clin Microbiol 2005; 43: 4175-4177.
53. Ryschkewitsch CF, Jensen PN, Monaco MC, Major EO. JC virus persistence following progressive multifocal leu-koencephalopathy in multiple sclerosis patients treated with natalizumab. Ann Neurol 2010; 68: 384-391.
54. Wuthrich C, Kesari S, Kim WK, et al. Characterization of lymphocytic infiltrates in progressive multifocal leukoen-cephalopathy: co-localization of CD81 T cells with JCV-infected glial cells. J Neurovirol 2006; 12: 116-128.
55. Huang D, Cossoy M, Li M, et al. Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patients. Ann Neurol 2007; 62: 34-39.
56. Miralles P, Berenguer J, Lacruz C, et al. Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. AIDS 2001; 15: 1900-1902.
57. Antinori A, Ammassari A, De Luca A, et al. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology 1997; 48: 687-694.
58. Levy RM, Russell E, Yungbluth M, Hidvegi DF, Brody BA, Dal Canto MC. The efficacy of image-guided stereotactic brain biopsy in neurologically symptomatic acquired immunodeficiency syndrome patients. Neurosurgery 1992; 30: 186-189.
59. Silver SA, Arthur RR, Erozan YS, Sherman ME, McArthur JC, Uematsu S. Diagnosis of progressive multifocal leukoencephalopathy by stereotactic brain biopsy utilizing immunohistochemistry and the polymerase chain reaction. Acta Cytol 1995; 39: 35-44.
60. Brooks BR, Walker DL. Progressive multifocal leukoen-cephalopathy. Neurol Clin 1984; 2: 299-313.